ESLA Estrella Immunopharma, Inc. Common Stock · XNAS
0.71 +38.7% as of Nov 10, 13:55 ET
fans
What's happening Live detector signal Generated 00:51 ET
Share structure
Free float
15.1M
2026-05-20
Shares out
43.5M
latest detail
Market cap
$32.5M
at ref price
Short interest
6.1%
2026-10-30
Float rotation
0.17×
latest snapshot
20d dollar vol
$3.0M
baseline
Supply intelligence
Gap quality
clean gap · 72
live supply-pressure model
Supply factor
positive gap demand
detector reason
Supply factor
meaningful float rotation
detector reason
Supply factor
nano-cap supply profile
detector reason

This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.

Filings and news
2026-11-10 13:55 ETSignalEstrella Immunopharma, Inc. Common Stock is up 38.7%, at 0.71, on $1.9M traded, 0.17× float rotation. Score 74. Primary driver: 17.3% float rotation. Supply intelligence: clean gap · 72.
2026-10-298-KItem 5.02 — Director or officer departure/election/appointment; Item 8.01 — Other events +1 more SEC
2026-09-088-KItem 3.01 — Notice of delisting or failure to satisfy listing rule SEC
2026-08-218-KItem 3.01 — Notice of delisting or failure to satisfy listing rule SEC
2026-08-1310-QQuarterly report SEC
2026-07-08 23:06 ETLegalAGIG: Abbott Cooper PLLC Announces Investigation on Behalf of Abundia Global Impact Group, Inc. (Formerly Houston American Energy Corp.) Stockholders News
2026-07-08 22:54 ETLegalESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. Stockholders News
2026-06-308-KCurrent report filed with SEC. SEC
2026-05-27DEF 14AProxy statement SEC
2024-01-17 08:18 ETOfferingWhy DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket News
Latest detector signalscore 74
score 74